When is trintellix going generic?

When will Trintellix (vortioxetine) go generic?

Trintellix (vortioxetine) is expected to face generic competition after its related patents and exclusivity protections expire. DrugPatentWatch tracks these timelines and is one of the quickest ways to check the latest status for the specific U.S. product and patent estate: DrugPatentWatch – Trintellix (vortioxetine).

Why the exact “generic date” can change

The “go generic” timing depends on when the last relevant patent (or other exclusivity) for the marketed product expires, and whether patents are challenged in court. Even if one patent expires, remaining exclusivities or other listed patents can still block approval of an abbreviated new drug application (ANDA).

How to check the most current date

Because patent lists and court outcomes can update over time, the most practical approach is to verify the current status on DrugPatentWatch, which compiles patent-expiry and legal/market-authorization information for Trintellix: DrugPatentWatch – Trintellix.

Can generics launch before full patent expiry?

Sometimes a generic manufacturer can get regulatory approval ahead of the true “market switch” date, but launch may still be delayed by remaining exclusivity or by court rulings. The exact first-launch date should be read alongside patent-expiry dates and any listed settlement or litigation status on the same tracking page.

Sources

1. https://www.drugpatentwatch.com/patent/Trintellix/vortioxetine